Invesco’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.05M Buy
64,117
+3,321
+5% +$175K ﹤0.01% 2374
2025
Q4
$3.19M Sell
60,796
-4,531
-7% -$271K ﹤0.01% 2425
2025
Q3
$4.23M Sell
65,327
-1,321
-2% -$75.8K ﹤0.01% 2303
2025
Q2
$3.24M Buy
66,648
+38,691
+138% +$1.5M ﹤0.01% 2387
2025
Q1
$951K Sell
27,957
-5,833
-17% -$247K ﹤0.01% 2854
2024
Q4
$1.33M Buy
33,790
+2,010
+6% +$94.9K ﹤0.01% 2793
2024
Q3
$1.49M Sell
31,780
-1,120
-3% -$56.8K ﹤0.01% 2740
2024
Q2
$1.78M Buy
32,900
+1,332
+4% +$77K ﹤0.01% 2635
2024
Q1
$2.15M Sell
31,568
-19,616
-38% -$1.4M ﹤0.01% 2636
2023
Q4
$3.2M Sell
51,184
-84,939
-62% -$4.7M ﹤0.01% 2443
2023
Q3
$6.18M Buy
136,123
+2,061
+2% +$106K ﹤0.01% 2095
2023
Q2
$7.53M Sell
134,062
-3,221
-2% -$183K ﹤0.01% 2008
2023
Q1
$6.21M Buy
137,283
+12,219
+10% +$593K ﹤0.01% 2117
2022
Q4
$5.08M Sell
125,064
-1,083
-0.9% -$57.5K ﹤0.01% 2238
2022
Q3
$8.24M Sell
126,147
-1,311
-1% -$95K ﹤0.01% 1923
2022
Q2
$7.75M Buy
127,458
+9,335
+8% +$549K ﹤0.01% 2018
2022
Q1
$7.42M Buy
118,123
+26,428
+29% +$1.66M ﹤0.01% 2143
2021
Q4
$6.95M Sell
91,695
-4,757
-5% -$416K ﹤0.01% 2222
2021
Q3
$10.8M Sell
96,452
-31,768
-25% -$3.99M ﹤0.01% 1962
2021
Q2
$20.8M Buy
128,220
+10,438
+9% +$1.27M 0.01% 1595
2021
Q1
$14.4M Sell
117,782
-187,564
-61% -$28.3M ﹤0.01% 1742
2020
Q4
$46.8M Buy
305,346
+163,412
+115% +$19.3M 0.01% 1052
2020
Q3
$11.9M Sell
141,934
-42,578
-23% -$3.78M ﹤0.01% 1571
2020
Q2
$13.6M Sell
184,512
-5,795
-3% -$339K ﹤0.01% 1467
2020
Q1
$8.07M Buy
190,307
+56,928
+43% +$2.94M ﹤0.01% 1634
2019
Q4
$8.12M Buy
133,379
+103,822
+351% +$5.67M ﹤0.01% 1890
2019
Q3
$1.21M Buy
+29,557
New +$1.41M ﹤0.01% 2891
2018
Q3
Sell
-75,075
Closed -$4.41M 3891
2018
Q2
$4.41M Buy
+75,075
New +$4.28M ﹤0.01% 2221

Other funds holding CRSP